A randomized, placebo-controlled, double-blinded clinical trial: evaluating the effects of Cistanche deserticola Y.C.Ma and Osmanthus fragrans (Thunb.) Lour. extracts on aging-related skin conditions in healthy women

Background Skin aging is a multifactorial process driven by oxidative stress and inflammation, leading to deterioration of barrier function and visible morphological changes. Although Cistanche deserticola and Osmanthus fragrans possess documented antioxidant and anti-inflammatory properties, their combined effects on aging-related skin conditions have not been clinically evaluated. Objective This randomized, double-blind, placebo-controlled clinical trial aimed to evaluate the efficacy and safety of a dietary supplement containing C. deserticola and O. fragrans extracts in improving skin barrier function and aging-related skin parameters. Subjects A 28-day randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate skin trans-epidermal water loss, pH, glossiness, thickness and chromaticity of a dietary supplement containing C. deserticola and O. fragrans extracts among 48 healthy women aged 26∼45 years. Results After 28 days of supplementation, the experimental group demonstrated significant improvements than the placebo group in all measured skin parameters. For the primary outcome, EP produced a significantly greater reduction in TEWL of the cheek (95%CI: −1.919 – −0.326, P = 0.007) and the inner forearm (95%CI: −0.872 – −0.228, P = 0.001) than PP group. Additionally, skin pH was significantly increased in EP group compared with PP (95%CI: 0.191–0.403, P < 0.001). The glossiness on both the cheek (95%CI: 4.239–8.485, P < 0.001) and the inner forearm (95%CI: 0.536–2.995, P = 0.006) was significantly increased in EP group than PP. EP also showed a greater reduction in the epidermal thickness (95%CI: −23.895 – −3.414, P = 0.010) and a significantly increase in the dermis thickness (95%CI: 22.171–140.888, P = 0.008) than PP group. Furthermore, brightness on both the cheek (95%CI: 0.785–2.273, P < 0.001) and the inner forearm (95%CI: 0.351–1.142, P < 0.001) was greatly increased by EP treatment than PP, while redness on both the cheek (95%CI: −2.232 – −0.486, P = 0.003) and the inner forearm (95%CI: −1.123 – −0.285, P = 0.001) was significantly lowered. No adverse events were reported throughout the study. Conclusions These findings suggest that C. deserticola and O. fragrans extracts combination may serve as a safe and effective nutraceutical intervention that improves skin barrier function and several aging-related skin parameters over a 28-day period. Future longer-term trials with extended follow-up or withdrawal phase are needed to confirm durability and long-term clinical relevance.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-20
DOI
https://doi.org/10.3389/fmed.2026.1983455
Primary Topic
Skin Protection and Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A randomized, placebo-controlled, double-blinded clinical trial: evaluating the effects of Cistanche deserticola Y.C.Ma and Osmanthus fragrans (Thunb.) Lour. extracts on aging-related skin conditions in healthy women

Yumeng Li, Baiyi Lu, Binhai Shi, Yansong Zhang et al.
3 links
Frontiers in Medicine
Skin Protection and Aging
article

A randomized, placebo-controlled, double-blinded clinical trial: evaluating the effects of Cistanche deserticola Y.C.Ma and Osmanthus fragrans (Thunb.) Lour. extracts on aging-related skin conditions in healthy women

Yumeng Li, Baiyi Lu, Binhai Shi, Yansong Zhang, Qinle Huang, Zhangtie Wang, Daoxin Dai
article en

Abstract

Background Skin aging is a multifactorial process driven by oxidative stress and inflammation, leading to deterioration of barrier function and visible morphological changes. Although Cistanche deserticola and Osmanthus fragrans possess documented antioxidant and anti-inflammatory properties, their combined effects on aging-related skin conditions have not been clinically evaluated. Objective This randomized, double-blind, placebo-controlled clinical trial aimed to evaluate the efficacy and safety of a dietary supplement containing C. deserticola and O. fragrans extracts in improving skin barrier function and aging-related skin parameters. Subjects A 28-day randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate skin trans-epidermal water loss, pH, glossiness, thickness and chromaticity of a dietary supplement containing C. deserticola and O. fragrans extracts among 48 healthy women aged 26∼45 years. Results After 28 days of supplementation, the experimental group demonstrated significant improvements than the placebo group in all measured skin parameters. For the primary outcome, EP produced a significantly greater reduction in TEWL of the cheek (95%CI: −1.919 – −0.326, P = 0.007) and the inner forearm (95%CI: −0.872 – −0.228, P = 0.001) than PP group. Additionally, skin pH was significantly increased in EP group compared with PP (95%CI: 0.191–0.403, P < 0.001). The glossiness on both the cheek (95%CI: 4.239–8.485, P < 0.001) and the inner forearm (95%CI: 0.536–2.995, P = 0.006) was significantly increased in EP group than PP. EP also showed a greater reduction in the epidermal thickness (95%CI: −23.895 – −3.414, P = 0.010) and a significantly increase in the dermis thickness (95%CI: 22.171–140.888, P = 0.008) than PP group. Furthermore, brightness on both the cheek (95%CI: 0.785–2.273, P < 0.001) and the inner forearm (95%CI: 0.351–1.142, P < 0.001) was greatly increased by EP treatment than PP, while redness on both the cheek (95%CI: −2.232 – −0.486, P = 0.003) and the inner forearm (95%CI: −1.123 – −0.285, P = 0.001) was significantly lowered. No adverse events were reported throughout the study. Conclusions These findings suggest that C. deserticola and O. fragrans extracts combination may serve as a safe and effective nutraceutical intervention that improves skin barrier function and several aging-related skin parameters over a 28-day period. Future longer-term trials with extended follow-up or withdrawal phase are needed to confirm durability and long-term clinical relevance.

Frontiers in MedicineVol. 13
Ministry of Agriculture and Rural Affairs (CN), Zhejiang University (CN)
Good health and well-being
Skin Protection and Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon